v3.26.1
Shareholder’s Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
May 30, 2025
Dec. 27, 2024
Aug. 20, 2024
Mar. 31, 2026
Dec. 31, 2025
Defined Benefit Plan Disclosure [Line Items]          
Common stock, shares authorized       500,000,000 500,000,000
Common stock, shares authorized       $ 0.0001 $ 0.0001
Capital contribution     $ 25,000    
Common stock, shares issued   1,437,500   1,708,575 1,708,575
Option exercised 5,000,000        
Share price $ 10.00        
Number of shares sold 595,000        
Gross proceed $ 55,950,000        
Ordinary shares to Sponsor       $ 253,875  
Proceed from private placement       $ 2,538,750  
Share issued       55,950  
Over-allotment Option       the exercise of the Representative’s over-allotment Option in part and the sales of Placement Units in the private placement, there were 7,303,575 ordinary shares issued and outstanding, including 5,595,000 ordinary shares subject to possible redemption, which are classified as temporary equity, and 1,708,575 ordinary shares. 1,708,575 ordinary shares issued and outstanding, consisted of 1,398,750 ordinary shares of founder shares, 253,875 ordinary shares from private placement and 55,950 ordinary shares to the underwriter.  
Public rights       $ 5,595,000 $ 5,595,000
Private rights       $ 253,875 $ 253,875
Founder Shares [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Founder Shares are subject to forfeiture   187,500      
Underwriters [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Option exercised 595,000        
Share issued 55,950